top of page
A L T I T U D E
Life Science Ventures
Companies in the News
Jan 24, 2022
eFFECTOR Therapeutics Provides Pipeline and Business Updates
Tomivosertib development strategy updated, including addition of a new cohort in Phase 2b KICKSTART trial in non-small cell lung cancer...
Jan 20, 2022
Nuvation Bio Announces FDA Clearance of IND Application for NUV-868 for the Advanced Solid Tumors
NEW YORK, Jan. 20, 2022 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet...
Jan 6, 2022
Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs
Amgen wants its future drugs to be multispecific, and so the biopharmaceutical company selected Generate Biomedicines for a $1.9 billion...
bottom of page